Cardiac antiplatelet therapy plays a crucial role in managing cardiovascular health by preventing blood clot formation, a common factor in heart-related issues. These therapeutic interventions primarily involve medications that inhibit platelet activity, reducing the risk of blood vessel blockages and potential heart events. Aspirin is a well-known antiplatelet agent widely used in cardiac care, working to hinder platelets from clumping together. Additionally, newer antiplatelet medications, such as clopidogrel and prasugrel, offer alternative options for individuals with specific cardiovascular conditions. The strategic use of antiplatelet therapy is tailored to each patient's unique medical profile, ensuring an effective and personalized approach to maintaining heart health. As ongoing research continues to uncover advancements in cardiovascular medicine, the role of cardiac antiplatelet therapy remains pivotal in the pursuit of comprehensive and targeted cardiovascular care
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China